STD 95 Parameters

Our STD 95 Parameters package offers a thorough, confidential screening suite designed to support sexual and reproductive health in Dubai by testing for a broad range of sexually transmitted infections and related urinary and molecular markers. The panel covers common bacterial, viral and fungal pathogens—including HPV, HIV and hepatitis markers—along with urine culture and sensitivity and other urine indicators, all processed in accredited laboratories. Results are delivered confidentially and are typically available within 12–72 hours after the laboratory receives the sample, enabling prompt discussion of findings with your healthcare provider. This reliable, discreet package is intended to help identify potential infections and provide clear information to guide appropriate next steps with a clinician.

• Atopobium Vaginae
• Bacteroides Fragilis
• BVAB2
• Candida Albicans
• Candida Dubliniensis
• Candida Glabrata
• Candida Krusei
• Candida Lusitaniae
• Candida Parapsilosis
• Candida Tropicalis
• Chlamydia Trachomatis
• Culture and Sensitivity (Urine)
• Cytomegalovirus (CMV)
• Gardnerella Vaginalis
• Haemophilus Ducreyi
• HBV DNA Detection by Real-Time PCR (Qualitative)
• HCV RNA Detection by Real-Time PCR (Qualitative)
• Helicobacter Pylori Antibody
• Hepatitis B Envelope Antigen (HBeAg)
• Hepatitis B Surface Antibody (HBsAb)
• Hepatitis B Surface Antigen (HBsAg)
• Hepatitis C Antibodies (Anti-HCV)
• Herpes Simplex Virus Type 1
• Herpes Simplex Virus Type 1 IgG Antibody
• Herpes Simplex Virus Type 1 IgM Antibody
• Herpes Simplex Virus Type 2
• Herpes Simplex Virus Type 2 IgG Antibody
• Herpes Simplex Virus Type 2 IgM Antibody
• HIV I & II Antibody and P24 Antigen
• HIV-1 RNA Detection by Real-Time PCR (Qualitative)
• HIV-2 RNA Detection by Real-Time PCR (Qualitative)
• HPV 28 Pathogen Low and High Risk
• Lactobacillus sp.
• Lymphogranuloma Venereum (LGV)
• Megasphaera Type 1
• Mobiluncus sp.
• Mycoplasma Genitalium
• Mycoplasma Hominis
• Neisseria Gonorrhoeae
• pH (Urine)
• Rapid Plasma Reagin (RPR)
• Specific Gravity (Urine)
• Treponema Pallidum
• Treponema Pallidum Hemagglutination (TPHA)
• Trichomonas Vaginalis
• Ureaplasma Parvum
• Ureaplasma Urealyticum
• Urine Ketone
• Urobilinogen
• Varicella Zoster Virus (VZV)

• Sexually active adults in Dubai seeking confidential, routine comprehensive STI screening.
• Anyone with recent unprotected sex or a new partner who wants testing for HIV, syphilis, chlamydia, gonorrhoea, HSV, HPV and hepatitis.
• People with multiple partners or higher exposure risk looking for regular monitoring and early detection.
• Couples planning pregnancy or fertility treatment who prefer thorough pre‑conception infectious screening.
• Individuals requiring molecular (PCR) tests or urine culture and sensitivity as part of follow‑up or specialist referral.

For the STD 95 Parameters package there are no specific prerequisites listed. To ensure a smooth and confidential experience in Dubai, follow these simple, non-specific steps and confirm any sample-related instructions when you book your appointment.

• Bring a valid ID and your Emirates ID or insurance information for registration and verification.
• Notify the clinic at booking if you have current symptoms, recent sexual exposure, or if you are pregnant.
• Ask at booking or on arrival about any sample-specific instructions so staff can prepare appropriately.
• Allow extra time for private consultation and counselling should you wish to discuss results confidentially.

The STD 95 Parameters report provides results for the comprehensive panel of markers included in this package, covering bacterial and viral pathogens (for example Chlamydia trachomatis, Neisseria gonorrhoeae, HSV‑1/2, HIV, HBV, HCV), HPV strains, Candida species, PCR-based detections and culture/sensitivity where applicable. Reports are delivered confidentially in Dubai within 12-72 Hours, After Laboratory Receives Sample. Please remember that test results are best interpreted in the context of symptoms, medical history, age, gender and other clinical factors rather than in isolation.

• Review any abnormal or borderline findings on the report and note any laboratory comments about significance or limitations.
• Discuss your results with a qualified healthcare professional in Dubai to understand implications for your health and next steps.
• Consider repeat testing when clinically appropriate—for example after recent exposure, during window periods, or if results are inconclusive.
• Follow any recommendations for further testing or specialist referral if your clinician advises additional evaluation to clarify results or guide care.